Trial Condition(s):
Regulatory Post Marketing Surveillance Study in Korea
The objective of the study is to investigate and collect post marketing data on the safety and efficacy of Visanne at follow-up visit after about 6 months of treatment and – for a subset of patients – at optional long-term follow-up visit after about 1 year of treatment under daily practice treatment conditions in Korean women and to obtain data on drug utilization on treatment for endometriosis.
- Signed and dated informed consent - Women diagnosed by a physician as having endometriosis - Women who are prescribed Visanne(dienogest 2mg)for the first time during the study period
- All contraindications according to the local marketing authorization have to be considered.
Locations | Status | ||
---|---|---|---|
Locations Investigative Site Many Locations, South Korea | Status Completed | Contact Us: E-mail: [email protected] Phone: +49 30 300139003 |
Visanne® (dienogest 2mg) Regulatory Post Marketing Surveillance Study in Korea
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1